$56MSeries D, 9 July 2025
Funds US commercialization and further development of Altius.
- Amount
- $56M
- Stage
- Series D
- Announced
- 9 July 2025
- Lead
- EQT Life Sciences
- Other investors
- US Venture Partners, Amzak Health, Osage University Partners, Sectoral Asset Management
- Use of funds
- Funds US commercialization and further development of Altius.
- Checked
- Amount and date matched across 2 press sources
- Sources
- Neuros Medical raises $56M Series D (date approx) massdevice.com
Neuros Medical raises $56M Series D (date approx) pulse2.com